EAST MEETS WEST


Japanese cases

The IPKat has been asked to draw his readers’ attention to the English translations of Japanese intellectual property cases available on the Japanese Institute of Intellectual Property’s website. Included are cases on all the major IP rights from a range of Japanese courts.


The database is still in development – comments and suggestions are encouraged to support@iip.or.jp


Naughty patent?

Lifestyle Extra reports that pharmaceutical company Phynova has obtained its first UK patent for a medicine based on Chinese medicine. The patent is in respect of PYN17, a botanical drug for the treatment of Hepatitis C.


The IPKat wonders precisely how much this drug is based on Chinese medicine. Presumably if it is too faithful, it should be barred from patentability.
EAST MEETS WEST EAST MEETS WEST Reviewed by Unknown on Tuesday, August 22, 2006 Rating: 5

1 comment:

  1. United Kingdom patent 2,411,114 entitled "A Botanical Drug or Dietary Supplement" was granted to Phynova Limited on 18th July 2006.
    The company has an agreement on drug development with a PRC organisation. In view of the inventors' names, Shouming Zhong and Hongwen Yu, there seems to be Chinese involvement.

    ReplyDelete

All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.

It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.

Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html

Powered by Blogger.